Harvard Navigating the Frontiers of Autism 2024
50 $
Format : Video + PDF
Despite advances in recent years, there are several aspects of autism and its clinical care that are not well understood. These ‘gray areas’ require exploration and further research to improve our capacity to provide tailored and optimal clinical care to patients. Clinicians must therefore keep up to date on this widely variable disorder and the latest innovative strategies to treat it.
New frontiers in our understanding of autism include: differences in how autism presents in girls; missed or inappropriate diagnosis in less obvious cases; the relationship between autism and gender identity; the overlap of autism and ADHD; and medication management that effectively addresses associated symptoms. Irritability is also a common problem in autism that is poorly defined and requires a multi-modal approach to care. Finally, there is a need to increase awareness of the double burden of patients with autism and racial, ethnic, linguistic, or social disadvantage who suffer delays in assessment and treatment.
This course aims to help clinicians better identify and treat these challenging aspects of autism. The day will culminate in a lived experience panel with several individuals and family members sharing their unique and impactful stories. All clinicians treating children, adolescents, or adults with autism are welcome!
Who Should Attend
- Psychologists
- Nurses
- Nurse Practitioners
- Physician Assistants
- Primary Care Physicians
- Specialty Physicians
- Social Workers
- Counselors
- Family Therapists
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify the markers of autism that most commonly present in girls or high-functioning individuals.
- Explore issues of gender identity in people with autism.
- Manage executive function in ASD using targeted strategies.
- Outline key approaches to the pharmacologic management of associated symptoms.
- Utilize clinical strategies to manage the symptom of irritability in ASD.
- Summarize the excess burden of suffering for minoritized patients with autism and how it results in further deleterious clinical outcomes.
- Review how the challenges of neurodiversity have been experienced by individuals with autism.
Friday, November 8, 2024
9:05 – 9:15 AM
Welcome & Introduction
Margaret Weiss, MD, PhD, FRCP (C); Peter Daniolos, MD, DFAACAP
9:15 – 10:15 AM
Understanding and Assessing Autism
Donna Henderson, PsyD
10:15 – 10:20 AM
Break
10:20 – 11:20 AM
Comorbid ADHD/ASD: Focus on Executive Function
Russell Schachar, MD, FRCP (C)
11:20 – 11:25 AM
Break
11:25 AM – 12:25 PM
Irritability in ASD
Raman Baweja, MBBS, MD, MS
12:25 – 1:05 PM
Lunch
1:05 – 2:05 PM
Psychopharmacology: Clinical Gaps and Recent Advances
Robyn Thom, MD
2:05 – 2:10 PM
Break
2:10 – 3:10 PM
“Stuck at the Crossroads”: The Intersection of Developmental Delay and Social Inequity in the Psychopharmacological Management of ASD
Margaret Weiss, MD, PhD, FRCP (C)
3:10 – 3:15 PM
Break
3:15 – 4:15 PM
The Common Intersections Among Gender Diversity, Autism, and Mental Health
Anna van der Miesen
4:15 – 4:20 PM
Break
4:20 – 5:50 PM
Living Through the Challenges of Neurodiversity (Patient & Clinician Conversation)
Margaret Weiss, MD, PhD, FRCP (C); Peter Daniolos, MD, DFAACAP
5:50 – 5:55 PM
Close Program
Margaret Weiss, MD, PhD, FRCP (C); Peter Daniolos, MD, DFAACAP
Related Products
